Skip to main content
Chugai Pharmaceutical Co., Ltd. (TYO:4519)
Japan flag Japan · Delayed Price · Currency is JPY
8,328.00
+1,243.00 (17.54%)
Apr 18, 2025, 3:30 PM JST

Chugai Pharmaceutical Revenue

In the year 2024, Chugai Pharmaceutical had annual revenue of 1.17T JPY with 5.33% growth. Chugai Pharmaceutical had revenue of 302.07B in the quarter ending December 31, 2024, with 10.32% growth.

Revenue
1,170.61B
Revenue Growth
+5.33%
P/S Ratio
11.71
Revenue / Employee
232.91M
Employees
7,778
Market Cap
13.70T

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20241,170.61B59.24B5.33%
Dec 31, 20231,111.37B-148.58B-11.79%
Dec 31, 20221,259.95B260.19B26.02%
Dec 31, 2021999.76B212.81B27.04%
Dec 31, 2020786.95B100.76B14.68%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Takeda Pharmaceutical Company 4,579.02B
Daiichi Sankyo Company 1,795.99B
HOYA Corporation 838.60B
Terumo 1,011.15B
Otsuka Holdings 2,329.86B
Astellas Pharma 1,867.63B
Olympus 993.33B
Shionogi & 456.87B
Revenue Rankings

Chugai Pharmaceutical News

More News